| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/27/1996 | US5494918 Anticholesterol agents |
| 02/27/1996 | US5494909 Antiischemic agents |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | US5494906 Treating metabolic bone disease |
| 02/27/1996 | US5494905 Vitamin D amide derivatives |
| 02/27/1996 | US5494894 Using a pentapeptide |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/27/1996 | CA2015738C Vitamin and mineral supplements |
| 02/25/1996 | CA2155986A1 .alpha.-phosphonosulfinate squalene synthetase inhibitors and method |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005188A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/22/1996 | WO1996005165A1 Retinoic acid x-receptor ligands |
| 02/22/1996 | WO1996005160A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004912A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/22/1996 | WO1996004895A1 Anthracyclinone derivatives and their use in amyloidosis |
| 02/22/1996 | CA2197099A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/22/1996 | CA2173623A1 Anthracyclinone derivatives and their use in amyloidosis |
| 02/21/1996 | EP0697403A1 Derivatives of glycinamides as cholecystokinin receptor agonists |
| 02/21/1996 | EP0697397A1 L-carnitine salt and compositions containing same |
| 02/21/1996 | EP0696918A1 Composition containing cholestyramine and method of producing the same |
| 02/21/1996 | EP0614455B1 Vitamin d amide derivatives |
| 02/21/1996 | EP0559746B1 Compositions containing psyllium |
| 02/21/1996 | CN1117292A Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/21/1996 | CN1117045A Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 02/21/1996 | CN1116929A Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended caments prevention or treatment of symptoms associated with the syndrome of spontaneous or prec..... |
| 02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 02/20/1996 | US5493051 Lifibrol and its use |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/20/1996 | US5492921 Preventing restenosis |
| 02/20/1996 | US5492912 Improves glucose tolerance |
| 02/20/1996 | US5492891 Treating with human growth hormone to increase levels of insulin-like growth factor |
| 02/20/1996 | US5492713 Nutriment preparation |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004276A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004275A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | WO1996003999A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 02/15/1996 | CA2196219A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196218A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/14/1996 | EP0696585A1 Novel bisoxadiazolidine derivative |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696453A2 Pediatric lipid emulsion |
| 02/14/1996 | EP0696284A1 Heterocyclic derivatives |
| 02/14/1996 | EP0696271A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives |
| 02/14/1996 | EP0696194A1 Use of indole derivatives as 5ht1 antagonists |
| 02/14/1996 | CN1116629A Monomeric insulin analog formulations |
| 02/14/1996 | CN1116626A Glucopyranoside benzothiophens |
| 02/14/1996 | CN1116543A Medicine for treatment of diabetes mellitus |
| 02/13/1996 | US5491242 Treating diabetes mellitus |
| 02/13/1996 | US5491216 Tri-arginine insulins |
| 02/13/1996 | US5491167 Inhibitors of cholesterol biosynthesis |
| 02/13/1996 | US5491150 Supplementary therpeutic agents for the treatment of immunodeficiency syndrome |
| 02/13/1996 | US5490987 Tableting of colestipol hydrochloride |
| 02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
| 02/08/1996 | WO1996003422A1 4-azasteroids with side-chain fluoroketones |
| 02/08/1996 | WO1996003420A1 3-carboxysteroids with a fluorinated side chain |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003400A1 4-indole derivatives as serotonin agonists and antagonists |
| 02/08/1996 | WO1996003392A1 Substituted thiazoles for the treatment of inflammation |
| 02/08/1996 | WO1996003371A1 N-acyl-n-(substituted cinnamoyl)ethylenediamine derivative |
| 02/08/1996 | WO1996003148A1 Method and drug for treating diabetes |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | CA2195847A1 Substituted thiazoles for the treatment of inflammation |
| 02/07/1996 | EP0695549A1 Use of polydeoxyribonucleotides in diabetic neuropathies |
| 02/07/1996 | EP0695183A1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
| 02/07/1996 | EP0611368B1 Substituted aminopyrimidines as angiotensin ii antagonists |
| 02/07/1996 | CN1116406A Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/06/1996 | US5489691 Cyclization; decyclization; hydrolysis; neutralization; salt formation |
| 02/06/1996 | US5489690 Process for trans-6[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 02/06/1996 | US5489602 Hypoglycemic and hypolipidemic agents |
| 02/06/1996 | US5489600 Anticholesterol and -lipemic agents; arteriosclerosis; enzyme inhibiors |
| 02/06/1996 | US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them |
| 02/01/1996 | WO1996002547A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 02/01/1996 | WO1996002488A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 02/01/1996 | WO1996002243A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 02/01/1996 | WO1996002242A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 02/01/1996 | CA2194889A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 01/31/1996 | EP0693933A1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | CN1115963A Cerebral metabolism activator containing glucose ester derivative |
| 01/31/1996 | CN1115768A Particles of cross-linked anion exchange agent and production of same |
| 01/30/1996 | US5488151 {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts |
| 01/30/1996 | US5487888 Iron-binding polymers for oral administration |
| 01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
| 01/30/1996 | CA1338018C 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6- thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, processes for the preparation of these compounds, their use as pharmaceuticals, pharmaceutical preparations and novel phenols and thiophenols |
| 01/30/1996 | CA1338017C Derivatives of physiologically active substance ml-236b and process for production thereof |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001813A1 CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001632A1 Method and compound for the treatment of hair loss |